These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22519861)

  • 1. Systemic delivery of transthyretin siRNA mediated by lactosylated dendrimer/α-cyclodextrin conjugates into hepatocyte for familial amyloidotic polyneuropathy therapy.
    Hayashi Y; Mori Y; Higashi T; Motoyama K; Jono H; Sah DW; Ando Y; Arima H
    Amyloid; 2012 Jun; 19 Suppl 1():47-9. PubMed ID: 22519861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
    Hayashi Y; Mori Y; Yamashita S; Motoyama K; Higashi T; Jono H; Ando Y; Arima H
    Mol Pharm; 2012 Jun; 9(6):1645-53. PubMed ID: 22510029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy.
    Hayashi Y; Higashi T; Motoyama K; Jono H; Ando Y; Onodera R; Arima H
    Biol Pharm Bull; 2019; 42(10):1679-1688. PubMed ID: 31582656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
    Anno T; Higashi T; Hayashi Y; Motoyama K; Jono H; Ando Y; Arima H
    J Drug Target; 2014 Dec; 22(10):883-90. PubMed ID: 25051178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes.
    Arima H; Yamashita S; Mori Y; Hayashi Y; Motoyama K; Hattori K; Takeuchi T; Jono H; Ando Y; Hirayama F; Uekama K
    J Control Release; 2010 Aug; 146(1):106-17. PubMed ID: 20678990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
    Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
    Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of siRNA complexes with polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) on endogenous gene expression.
    Arima H; Tsutsumi T; Yoshimatsu A; Ikeda H; Motoyama K; Higashi T; Hirayama F; Uekama K
    Eur J Pharm Sci; 2011 Oct; 44(3):375-84. PubMed ID: 21896329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors.
    Arima H; Motoyama K; Higashi T
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1204-14. PubMed ID: 23602906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective silencing of a mutant transthyretin allele by small interfering RNAs.
    Kurosawa T; Igarashi S; Nishizawa M; Onodera O
    Biochem Biophys Res Commun; 2005 Nov; 337(3):1012-8. PubMed ID: 16225852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Use of Thioalkylated Mannose-Modified Dendrimer (G3)/α-Cyclodextrin Conjugate as an NF-κB siRNA Carrier for the Treatment of Fulminant Hepatitis.
    Motoyama K; Mitsuyasu R; Akao C; Abu Hashim II; Sato N; Tanaka T; Higashi T; Arima H
    Mol Pharm; 2015 Sep; 12(9):3129-36. PubMed ID: 26270769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo.
    Hayashi Y; Higashi T; Motoyama K; Mori Y; Jono H; Ando Y; Arima H
    J Drug Target; 2013 May; 21(5):487-96. PubMed ID: 23570609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo siRNA delivery to hepatocyte utilizing ternary complexation of lactosylated dendrimer/cyclodextrin conjugates, siRNA and low-molecular-weight sacran.
    Hayashi Y; Higashi T; Motoyama K; Jono H; Ando Y; Arima H
    Int J Biol Macromol; 2018 Feb; 107(Pt A):1113-1121. PubMed ID: 28964842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
    Tsutsumi T; Hirayama F; Uekama K; Arima H
    J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis and therapy for transthyretin related amyloidosis].
    Ando Y; Jono H
    Rinsho Byori; 2008 Feb; 56(2):114-20. PubMed ID: 18402051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene therapy in familial amyloidotic polyneuropathy by single-stranded oligonucleotides (SSOs)].
    Nakamura M; Ando Y
    Rinsho Byori; 2004 Oct; 52(10):804-12. PubMed ID: 15624495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
    Arima H; Arizono M; Higashi T; Yoshimatsu A; Ikeda H; Motoyama K; Hattori K; Takeuchi T; Hirayama F; Uekama K
    Cancer Gene Ther; 2012 May; 19(5):358-66. PubMed ID: 22402627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of thioalkylated mannose-modified dendrimer (G3)/α-cyclodextrin conjugates as antigen-presenting cell-selective siRNA carriers.
    Motoyama K; Mitsuyasu R; Akao C; Tanaka T; Ohyama A; Sato N; Higashi T; Arima H
    AAPS J; 2014 Nov; 16(6):1298-308. PubMed ID: 25236864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of polyamidoamine dendrimer conjugate with glucuronylglucosyl-β-cyclodextrin (G3) as a novel carrier for siRNA.
    Abdelwahab AF; Ohyama A; Higashi T; Motoyama K; Khaled KA; Sarhan HA; Hussein AK; Arima H
    J Drug Target; 2014 Dec; 22(10):927-34. PubMed ID: 25148608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro and In Vivo Tumor-Targeting siRNA Delivery Using Folate-PEG-appended Dendrimer (G4)/α-Cyclodextrin Conjugates.
    Ohyama A; Higashi T; Motoyama K; Arima H
    Bioconjug Chem; 2016 Mar; 27(3):521-32. PubMed ID: 26715308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
    Ando Y
    Amyloid; 2003 Aug; 10 Suppl 1():55-66. PubMed ID: 14640043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.